Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Prizes

The 2011 Rowley Prize is awarded to
Dr John Goldman 

rowley-prize-2011_130px

Professor John M. Goldman has a long-standing interest in the biology and therapy of CML. He was until 2004 Chairman of the Department of Haematology at Imperial College London, Director of the Leukaemia Research Fund Centre for Adult Leukaemia and Clinical Director of the Haematology Department at the Hammersmith Hospitals NHS Trust. Thereafter he took up a 2-year appointment as Fogarty Scholar at the National Institutes of Health in Bethesda USA.  He is now active as Emeritus Professor of Haematology at Imperial College London and Medical Director of the Anthony Nolan Trust.

The 2010 Rowley Prize is awarded to Dr. Moshe Talpaz

The winner of the Rowley Prize for 2010 is MD Moshe Talpaz, awarded at the start of moshe talpazthe ESH-iCMLf meeting in September 2010 in Washington DC. Dr Janet Rowley has kindly given the iCMLf permission to name this award in her honour. Dr Moshe Talpaz is Associate Chief of the Division of Hematology/Oncology at the University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA. He is one of the leading clinical investigators in hematologic malignancies worldwide.

The first winner of the Rowley Prize for 2009 was Dr Brian Druker

rowley_druker_goldman_400Dr Brian Druker is Joint Professor, Cell and Developmental Biology and JELD-WEN Chair of Leukemia Research at the Oregon Health and Science University. He is also an HHMI scholar. Dr Druker was responsible for bringing imatinib, the first tyrosine kinase inhibitor, to the clinic for patients with CML.